Trial intelligence / Profile preview

B-cell Immunity to 2009-2010 Influenza Vaccines

NCT02133781Phase 4Completed

Sponsor
Stanford University
Start
Jul 2009
Primary completion
Dec 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Fluzone Trivalent, live attenuated influenza vaccine in influenza, sponsored by Stanford University. Started Jul 2009; status: completed.

02

Drugs

Fluzone Trivalentlive attenuated influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02133781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02133781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call